Aminoquinazolines which inhibit signal transduction mediated by tyrosine kinases

US6740651B2 · kind B2 · utility

Assignee

• BOEHRINGER INGELHEIM PHARMA GMBH & CO. KG · DE

Inventors

• Frank Himmelsbach · Mittelbiberach, DE
• Elke Langkopf · Biberach an der Riß, DE
• Birgit Jung · Laupheim, DE
• Stefan Blech · Warthausen, DE
• Flavio Solca · Wien, AT

Key dates

• Filing date: Aug 22, 2001
• Grant date: May 25, 2004
• Expiry date: Aug 22, 2021

Classification

• Technology area (CPC A): Human Necessities
• CPC primary: A61P35/00
• WIPO field: Organic fine chemistry
• WIPO sector: Chemistry

Abstract

Compounds of the formula having an inhibitory effect on signal transduction mediated by tyrosine kinases, and the use thereof for treating diseases, particularly tumoral diseases, diseases of the lungs and respiratory tract.